Steady-State Kinetics of the Quinolone Derivatives Ofloxacin, Enoxadn, Ciprofloxacin and Pefloxacin during Maintenance Treatment with Theophylline

Drugs

Volumn 34, Issue 1, 1987, Pages 159-169

  Wijnands, W J A ^a   Vree, T B ^b   Baars, A M ^b   van Herwaarden, C L A ^a  

^a DEVENTER HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI INFECTIVE AGENTS; ANTIINFECTIVE AGENT; CIPROFLOXACIN; DRUG DERIVATIVE; ENOXACIN; NAPHTHYRIDINE DERIVATIVE; NORFLOXACIN; OFLOXACIN; OXAZINE DERIVATIVE; PEFLOXACIN; QUINOLINE DERIVATIVE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DRUG INTERACTION; FEMALE; HUMAN; MALE;

AGED; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; COMPARATIVE STUDY; DRUG INTERACTIONS; ENOXACIN; FEMALE; HUMAN; MALE; MIDDLE AGE; NAPHTHYRIDINES; NORFLOXACIN; OFLOXACIN; OXAZINES; PEFLOXACIN; QUINOLINES; THEOPHYLLINE;

EID: 0023475833     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198700341-00034     Document Type: Article

References (38)

1. Pharmacokinetics of ofloxacin in normal subjects and in patients with mild to moderate renal insufficiency
2. In-vitro activity of newer quinolones against aerobic bacteria
3. Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans
4. Pharmacology of cinoxacin in humans
5. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration
6. Pharmacokinetik von Ofloxacin (Hoer 280)
7. Pefloxacin kinetics in cirrhosis
8. Pharmacokinetics of intravenously administered ciprofloxacin in intensive care patients with acute renal failure
9. Pharmacokinetics of ofloxacin in humans after various single oral doses
10. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400mg bid) in young healthy children
11. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers
12. Interactions on the gastrointestinal absorption of ciprofloxacin
13. Sulphonamides and miscellaneous antibacterial and antiviral drugs
14. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy
15. Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy
16. Multiple-dose pharmacokinetics and tissue penetration of ciprofloxacin, 500mg tid
17. The pharmacokinetics and tissue penetration of ofloxacin
18. Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans
19. Pharmacokinetics of pefloxacin in renal insufficiency
20. Ciprofloxacin pharmacokinetics in renal failure
21. Absorption and excretion of ofloxacin in patients with impaired renal function
22. Dose linearity and other pharmacokinetics of ofloxacin: a new broad-spectrum antimicrobial agent
23. Clinical pharmacokinetics of sulfonamides
24. High-performance liquid chromatography and preliminary pharmacokinetics of enoxacin and its 4-oxo metabolite in human plasma, urine and saliva
25. Pharmacokinetics: metabolism and renal excretion of quinolones in man
26. Ofloxacin: clinical and pharmacokinetic study in health and disease (preliminary data)
27. Mechanism of renal excretion of ciprofloxacin (Bay 09867), a new quinolone carboxylic acid derivative, in humans
28. The pharmacokinetics and tissue penetration of orally administered enoxacin, norfloxacin and ciprofloxacin
29. The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers
30. Enoxacin decreases the clearance of theophylline in man
31. Enoxacin in lower respiratory tract infections
32. The influence of quinolone derivatives on theophylline clearance